CD­MOs Nephron and Can­ton each raise hun­dreds of mil­lions in fi­nanc­ing

Nephron Phar­ma­ceu­ti­cals and Can­ton Bi­o­log­ics re­cent­ly an­nounced cap­i­tal rais­es to­tal­ing hun­dreds of mil­lions of dol­lars, join­ing the grow­ing mar­ket for con­tract and de­vel­op­ment man­u­fac­tur­ing com­pa­nies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER